ArticleCase reports in gastroenterology2010
Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention.
Shogo Ohkoshi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.